Corticosteroid therapy and cataract: prevalence and relation to time of use and cumulative dose

Related authors

• Fernanda Ziger
• Rommel Josuel Zago
• Marcelo Gehlen
• Marília B. Silva
• Thelma L. Skare

Related articles

• Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial
• Multiple evanescent white dot syndrome (MEWDS) following inactivated COVID-19 vaccination (Sinovac-CoronaVac)
• Evaluation of the impact of subepithelial corneal infiltrates on corneal biomechanics after epidemic keratoconjunctivitis
• Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients
• Acute corneal melting one week after an uncomplicated cataract surgery in a patient who previously underwent eyelid radiation and with undiagnosed rheumatoid arthritis: a case report
• Vancomycin-associated hemorrhagic occlusive retinal vasculitis masquerading as central retinal vein occlusion
• Comparison between objective and subjective postoperative intraocular pressure immediately after cataract surgery
• Evaluation of the pachychoroid spectrum in patients with mild autonomous cortisol secretion
• Trabecular micro-bypass implant (iStent^®) in a case of bilateral acute depigmentation of the iris
• Long-term outcomes of intraoperative triamcinolone injection versus postoperative oral prednisolone in congenital cataract surgery

Click here to search